4.5 Wound Bed Preparation and Debridement Concepts
Key Takeaways
- Wound bed preparation is organized by the TIME framework: Tissue, Infection/Inflammation, Moisture, and Edge (epithelial advancement).
- Five debridement methods: autolytic, enzymatic (collagenase), mechanical, sharp (selective), and surgical; biosurgical (maggot) is a sixth.
- Stable, dry, intact eschar on an ischemic heel is left in place ('stable, do not debride') until perfusion is restored or it becomes unstable.
- Screen for contraindications before any debridement: poor perfusion, anticoagulation/low platelets, exposed structures, severe pain, palliative goals, and scope/authorization.
Prepare the Bed Before Expecting Closure
The Treatment domain includes wound bed preparation, the systematic work of making the wound surface and surrounding conditions support healing. The standard organizing tool is the TIME framework:
- T (Tissue): remove nonviable tissue (slough, eschar) so the bed is viable.
- I (Infection/Inflammation): control bioburden and excessive inflammation.
- M (Moisture): achieve moisture balance, neither desiccated nor macerated.
- E (Edge): ensure the wound edge is advancing; address rolled (epibole), undermined, or non-migrating edges.
The exact acronym matters less than the reasoning: what barrier is visible, what must the team address before the wound can progress, and what is safe for this patient and setting? The updated TIMERS variant adds R (Repair/Regeneration, including advanced therapies and skin substitutes) and S (Social and patient factors, such as nutrition, perfusion, adherence, and resources), reflecting that wound bed preparation is never just about the local bed.
| TIME Element | Treatment Question | Exam Caution |
|---|---|---|
| Tissue | Is debridement indicated and authorized? | Do not debride stable ischemic heel eschar |
| Infection/Inflammation | Are local or systemic signs present? | Do not treat colonization as invasive infection |
| Moisture | Too dry or too wet? | Avoid one dressing for all drainage levels |
| Edge | Is the edge rolled, undermined, or stalled? | Don't blame the product alone; check pressure/perfusion |
Debridement Methods and the Stable-Eschar Rule
Debridement removes nonviable tissue or debris when appropriate. Know the methods and their scope.
| Method | How It Works | Speed / Selectivity | Key Notes |
|---|---|---|---|
| Autolytic | Body's own enzymes under a moisture-retentive dressing | Slow, selective | Painless; avoid if infection needs faster control |
| Enzymatic | Topical agent (e.g., collagenase) digests devitalized tissue | Moderate, selective | Requires an order; cross-hatch eschar to expose tissue |
| Mechanical | Wet-to-dry, irrigation, monofilament pad, hydrotherapy | Fast, nonselective | Wet-to-dry can damage healthy tissue and is painful |
| Sharp (conservative) | Scissors/curette/scalpel removing loose nonviable tissue | Fast, selective | Requires training, competency, and scope authorization |
| Surgical | OR excision of large/deep nonviable tissue | Fastest, selective | Physician/advanced practice; deep infection, large area |
| Biosurgical | Medical-grade larvae | Selective | Niche; for select nonhealing wounds |
The Heel Eschar Rule
A heel with dry, stable, intact black eschar and poor perfusion is the classic exam trap. Current guidance (NPIAP) is to leave stable, dry, adherent eschar on an ischemic limb intact: it acts as a natural biological cover. Do not debride or soften it until perfusion is restored or signs of instability appear, such as new erythema, fluctuance, drainage, malodor, or edema, which warrant urgent evaluation.
Screen Contraindications First
Before selecting any debridement, screen for danger cues: poor perfusion (absent pulses, low ankle-brachial index), anticoagulation or low platelets (bleeding risk), exposed bone, tendon, or hardware, severe uncontrolled pain, palliative goals of care, and your scope, competency, and orders. NAWCO certification does not override your state practice act or employer policy. The exam-safe answer identifies the barrier with the TIME lens, then chooses the method that is appropriate, authorized, and safe, rather than reflexively debriding all necrosis.
Matching Method to Goal and Urgency
Method selection follows the clinical goal. When the wound is clean enough to wait and the patient cannot tolerate a faster method, autolytic or enzymatic debridement is gentle and selective. When devitalized tissue is fueling infection or the wound is deteriorating quickly, faster selective methods (conservative sharp or surgical) move to the front, because slow autolysis under occlusion is unsafe in spreading infection.
Maintenance debridement, repeated low-grade removal of slough and biofilm at successive visits, is a recurring theme: biofilm reforms within days, so a single debridement rarely finishes the job, and the answer that schedules ongoing wound hygiene usually beats the one-and-done option.
Document before and after debridement: tissue types and percentages (for example, 60 percent slough, 40 percent granulation), measurements, exudate, and pain, plus the consent and tolerance for any sharp procedure. A wound that bleeds appropriately at the margins of viable tissue and stops with light pressure is a reassuring sign during conservative sharp debridement, whereas brisk or uncontrolled bleeding, severe pain, or uncertainty about the tissue plane is a cue to stop and escalate.
Across every method, the WCC priority is the same: confirm perfusion, control bioburden, balance moisture, support the advancing edge, and act only within scope and orders.
Slough Versus Eschar, and Edge Effects
Distinguish the two devitalized tissues the exam tests. Slough is moist, stringy, yellow-to-tan nonviable tissue; eschar is dry, leathery, black or brown necrotic tissue. Slough often responds well to autolytic or enzymatic methods and to mechanical disruption, whereas thick eschar may need cross-hatching to let an enzymatic agent penetrate, or sharp/surgical removal when the wound must be staged or is infected, except for the protected stable ischemic heel eschar discussed above.
The wound edge (epibole) is a high-yield E concept. A rolled or curled-under edge means epithelial cells have migrated down the wound wall and met themselves, halting closure; the wound cannot resurface until that edge is reactivated, typically through debridement or other ordered intervention to restart migration. Undermining and tunneling represent edge-related dead space that must be measured (depth in centimeters and direction by the clock method, with the head as 12 o'clock) and lightly filled.
Whenever a stem reports a non-advancing edge despite a reasonable dressing, the answer usually lies in addressing the edge and the systemic and offloading factors, not in swapping the central product.
A heel wound has dry, stable, intact eschar and the patient has absent pedal pulses. What is the safest WCC exam response?
Which factors must be screened before selecting a debridement method?
In the TIME framework, what does the 'E' direct the clinician to evaluate?